Refresh

Sterling Biotech Ltd. - Research Center

512299 STERLINBIO Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 17 Mar ' 16 Dec ' 14 Dec ' 13 Dec ' 12
Income

Operating income

368.43 523.99 666.95 718.07 834.77
Expenses

Material consumed

273.46 354.44 465.51 511.84 580.94

Manufacturing expenses

- - - - -

Personnel expenses

54.41 66.11 51.67 54.68 53.68

Selling expenses

- - - - -

Adminstrative expenses

27.98 38.99 38.53 56.87 52.55

Expenses capitalised

- - - - -

Cost of sales

355.85 459.53 555.71 623.39 687.17

Operating profit

12.57 64.46 111.24 94.68 147.60

Other recurring income

3.98 7.85 3.68 4.26 7.02

Adjusted PBDIT

16.55 72.31 114.92 98.94 154.62

Financial expenses

369.80 414.78 469.51 437.71 412.33

Depreciation

263.55 345.14 276.57 254.32 258.83

Other write offs

- - - - -

Adjusted PBT

-616.80 -687.62 -631.16 -593.08 -516.54

Tax charges

-204.34 -237.15 -204.78 -192.43 -167.98

Adjusted PAT

-412.46 -450.47 -426.38 -400.65 -348.56

Non recurring items

24.80 - - - -1.22

Other non cash adjustments

- - -31.32 - -

Reported net profit

-387.66 -450.47 -457.71 -400.65 -349.77

Earnigs before appropriation

-878.30 440.98 -40.17 417.54 828.90

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-878.30 440.98 -40.17 417.54 828.90
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com